Literature DB >> 8479785

Pyrexia in hospitalised spinal cord injury patients.

P S Beraldo1, E G Neves, C M Alves, P Khan, A C Cirilo, M R Alencar.   

Abstract

To discover the frequency of pyrexia in spinal cord injury (SCI) patients in the Hospital for Medicine of the Locomotor System (HMLS/SARAH), a review study was undertaken. For a period of 3 months, all new episodes of fever were recorded. During the study 221.3 patients/month were observed. The age ranged from 14 to 60 years and time of lesion from 1 to 6,264 days: 85 patients were paraplegia or paraparetic, and 44 tetraplegic or tetraparetic. At the beginning of the study 10.8% of the patients had fever. During follow up, we observed a rate of 33.9 new incidences per 100 patients/month. In 77.3% only one cause was identified, and in 8% no cause could be defined. The commonest causes were urinary tract infection (UTI) (44.3%), and soft tissue infections (11.4%). Frequent causes of fever in the acute stage other than UTI were complications related to the initial trauma and thromboembolic disease (p < 0.05). These results demonstrate the high incidence of fever in patients with SCI, in addition to providing a useful approach for diagnosis and management.

Entities:  

Mesh:

Year:  1993        PMID: 8479785     DOI: 10.1038/sc.1993.35

Source DB:  PubMed          Journal:  Paraplegia        ISSN: 0031-1758


  11 in total

1.  Incidence, etiology, and risk factors for fever following acute spinal cord injury.

Authors:  William McKinley; Shane McNamee; Michelle Meade; Katrina Kandra; Nicole Abdul
Journal:  J Spinal Cord Med       Date:  2006       Impact factor: 1.985

2.  Urodynamic Management of Neurogenic Bladder in Spinal Cord Injury.

Authors:  R Khanna; A S Sandhu; D Doddamani
Journal:  Med J Armed Forces India       Date:  2011-07-21

3.  Risk factors for febrile genito-urinary infection in the catheterized patients by with spinal cord injury-associated chronic neurogenic lower urinary tract dysfunction evaluated by urodynamic study and cystography: a retrospective study.

Authors:  Katsumi Shigemura; Koichi Kitagawa; Masashi Nomi; Akihiro Yanagiuchi; Atsushi Sengoku; Masato Fujisawa
Journal:  World J Urol       Date:  2019-04-04       Impact factor: 4.226

4.  Fever during rehabilitation in patients with traumatic spinal cord injury: analysis of 392 cases from a national rehabilitation hospital in Turkey.

Authors:  Sibel Unsal-Delialioglu; Kurtulus Kaya; Sule Sahin-Onat; Fazil Kulakli; Canan Culha; Sumru Ozel
Journal:  J Spinal Cord Med       Date:  2010       Impact factor: 1.985

5.  Development of acute promyelocytic leukemia in a patient with tetraplegia while in inpatient rehabilitation: A case report.

Authors:  Christopher A Beal; Michael C Krouse; Jeffrey T Tubbs
Journal:  J Spinal Cord Med       Date:  2017-09-20       Impact factor: 1.985

6.  Does the CDC Definition of Fever Accurately Predict Inflammation and Infection in Persons With SCI?

Authors:  Michelle Trbovich; Carol Li; Shuko Lee
Journal:  Top Spinal Cord Inj Rehabil       Date:  2016

7.  Retrospective study for risk factors for febrile UTI in spinal cord injury patients with routine concomitant intermittent catheterization in outpatient settings.

Authors:  S Mukai; K Shigemura; M Nomi; A Sengoku; F Yamamichi; M Fujisawa; S Arakawa
Journal:  Spinal Cord       Date:  2015-10-13       Impact factor: 2.772

8.  Non-infectious Fever After Acute Spinal Cord Injury in the Intensive Care Unit.

Authors:  Fatma Ülger; Mehtap Pehlivanlar Küçük; Çağatay Erman Öztürk; İskender Aksoy; Ahmet Oğuzhan Küçük; Naci Murat
Journal:  J Spinal Cord Med       Date:  2017-10-13       Impact factor: 1.985

Review 9.  Neurogenic Fever after Acute Traumatic Spinal Cord Injury: A Qualitative Systematic Review.

Authors:  Katherine E Savage; Christina V Oleson; Gregory D Schroeder; Gursukhman S Sidhu; Alexander R Vaccaro
Journal:  Global Spine J       Date:  2016-01-30

10.  Fever in a paraplegia patient with a pressure ulcer.

Authors:  Meheroz H Rabadi
Journal:  Radiol Case Rep       Date:  2021-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.